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Abstract 
Background and aim: Hypertension as a risk factor for cardiovascular disease has growing 
prevalence. An increase in body weight is typically followed by an increase in blood pressure. 
This study aimed to investigate the association of general and central obesity with 
hypertension in Indonesian women using WHO and Indonesian classification systems. 
Methods: Cross-sectional study of Indonesian women aged 18 years or and more (313,714 
participants), using national level Indonesia National Basic Health Research (2013).  
Results: The prevalence of hypertension in Indonesian women in this study was 32.8%. Based 
on logistic regression analysis, hypertension was significantly associated with residential area, 
educational attainment, self-reported smoking status, cardiovascular disease, chronic kidney 
disease, diabetes mellitus, body mass index and waist circumference. Furthermore, the odds 
of having hypertension for general and central obesity according to WHO classification were 
adjusted odds ration (aOR) 2.61, 95% CI 2.52-2.70 and aOR 1.50, 95% CI 1.46-1.53. By 
Indonesian classification were aOR 2.21, 95% CI 2.16-2.26 and aOR 1.48, 95% CI 1.45-1.51.  
Conclusion: By using International WHO and standard Indonesia classification systems, 
general and central obesity were associated with hypertension in Indonesia women. Thus, 
not only general obesity but also central obesity should be used to assess obesity in 
Indonesian women.  
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1. Introduction 
Hypertension, known as a silent killer , contributes to cardiovascular disease, stroke 
and premature mortality (1). In Indonesia, cardiovascular disease is the number one cause of 
death (2). Both general and central obesity can be used to identify hypertension. (3,4). 
Furthermore, increase in arterial pressure was shown to be associated with weight gain and 
it is estimated that 60-70% of adults hypertension is related to adiposity (5). Thus, not only 
body mass index (BMI) but also waist circumference (WC) should be considered when 
assessing hypertension risk (6).   
In Indonesia, obesity has shown an increasing trend from year to year, with women 
having a higher prevalence of obesity (7). Moreover, women have greater population 
attributable risk levels related to excess weight for hypertension compared to men (8).  
The use of lower BMI cut-offs for the Indo-Asian population may be required to give 
optimal identification of people who are at risk of getting hypertension (9). People in Asia and 
Europe have different associations between body fat level, BMI score, and health risks (10). 
Thus it is important to consider the differences in BMI classification system to ensure a valid 
and reliable system to assess obesity (11). To the best of author’s knowledge, there are no 
other studies using recent and national scale data to examine the association of both general 
and central obesity with hypertension in Indonesian people.   
  
2. Methods  
2.1. Study population 
The subjects were Indonesian women aged 18 or above. The subjects were selected 
from Indonesia Basic Health Research (RISKESDAS) 2013, a national scale research that 
collected basic health data and indicators. Ethics for the survey was accepted by the 
committee of the National Institute of Health and Research Development, Ministry of Health, 
Republic of Indonesia. Pregnant subjects, and those with missing data on BMI, WC, and blood 
pressure, were excluded from the study. Hypertension was defined if one of the following 
status applied: systolic blood pressure (SBP) ≥ 140 mmHg; diastolic blood pressure (DBP) ≥ 90 
mmHg; or presently taking medicine for hypertension. This study used the mean of two times 
blood pressure measurements. 
 
 
2.2. General and central obesity categories 
The study used both World Health Organization and Indonesian classification for 
general and central obesity. General obesity was determined by BMI in kg/m2. WHO 
classification for BMI are underweight = BMI < 18.5 kg/m2; normal = BMI 18.5-24.99 kg/m2; 
overweight = BMI 25-29.99 kg/m2 and obese = BMI ≥ 30 kg/m2 (10). The Indonesian 
classification for BMI are underweight = BMI < 18.5 kg/m2; normal = BMI 18.5-24.99 kg/m2; 
overweight = BMI 25-26.99 kg/m2; and obese = BMI ≥ 27 kg/m2 (7). 
Central obesity was assessed by measuring waist circumference. In the study, the 
participants waist circumference size was measured at a central point between the lower ribs 
and iliac crest (12). The cut-offs for central obesity in WHO and Indonesian classifications are 
≥ 88 cm and ≥ 80 cm, respectively (7,13).  
 
2.3. Covariates  
Responses to the questions from the RISKESDAS questionnaire were used to obtain 
the covariates. Data for age was obtained from the household member question section. Age 
was grouped into young age = 18-39 years old, middle age = 40-54 years old, and old age = ≥ 
55 years old.  Residential area was classified as rural or urban areas. Marital status was 
classified as single or married. Educational attainment was categorized into three groups with 
high school as cut-off points (less than high school, high school, more than high school). The 
question about chronic kidney disease was phrased as “Have you ever been diagnosed you 
with chronic kidney disease (minimum of three consecutive months) by a doctor?” with yes 
and no responses. The question about diabetes mellitus was phrased as “Have you ever been 
diagnosed with diabetes mellitus by a doctor?” with yes and no responses. The question 
about hyperthyroid was phrased as “Have you ever been diagnosed with hyperthyroid by a 
doctor?” with yes and no responses. Cardiovascular disease data was obtained by a response 
to the question “Have you ever been diagnosed with heart failure or coronary heart disease 
by a doctor?” with yes and no responses. Self-reported smoking status was ascertained by 
the response from the tobacco consumption question and participants were grouped based 
on smoking history as: never, former or current smokers. Physical activity was obtained from 
the question: “Do you usually have continuous moderate physical activity for at least for 10 
minutes for each activity?” and participants were classified based on WHO Global Physical 
Activity Questionnaire analysis guide as less active if total physical activity time is 0 to < 150 
minutes and active, for 150 or more minutes/week (13).  
 
2.4. Statistical analysis 
Continuous variables were described as mean (M) ± standard deviation (SD) while 
categorical variables  as frequencies and percentages. The difference between hypertensive 
and normotensive groups in this study was compared by chi-squared test for categorical 
variables and paired t-test for continuous variables. Spearman correlation analysis was 
conducted to check the correlation of each research variable.  
Logistic regression analysis was done to measure the crude and adjusted odds ratio 
along with 95% confidence interval. Variables showing significant association with 
hypertension by alpha level <0.05 were selected as covariates in the adjusted logistic 
regression analysis. Hypertension was examined as outcome variable along with BMI and 
central obesity as predictor variables adjusted for age, residential area, educational 
attainment, chronic kidney disease, self-reported smoking status, cardiovascular disease, 
diabetes mellitus and hyperthyroid. All of the analyses were conducted in SPSS 22.0 (SPSS Inc., 
Chicago, IL). 
 
3. Results 
A total of 346,799 subjects aged ≥ 18 years old were examined. From those examined, 
33,085 participants were excluded with detail of 7464 women in pregnancy; 13,777 due to 
missing data on blood pressure measurement; 11,844 because of missing data on BMI and 
WC. The final analytical sample included 313,714 participants. 
Table 1 presents the prevalence of hypertension in Indonesian women based on their 
characteristics. The overall rate of hypertension was 32.8 % and it is significantly associated 
with residential area, educational attainment, cardiovascular disease, chronic kidney disease, 
self-reported smoking status, diabetes mellitus, hyperthyroid, BMI, and WC. Those people 
living in urban areas, married, and former smokers, tend to have higher hypertension 
prevalence. People with diabetes mellitus, hyperthyroid, cardiovascular or chronic kidney 
disease have higher hypertension prevalence compared to those without the disease. The 
comparison between hypertensive and normotensive groups was listed in Table 2. There 
were significant differences for all characteristics inspected between normotensive and 
hypertensive groups. The hypertensive group was significantly older in age; higher in weight, 
BMI, WC, SBP, and DBP, compared to normotensive group.  
In logistic regression model utilizing Indonesia classification, all covariates except for 
living in rural area and former smokers were significantly associated with hypertension. The 
odds for general obese people to get hypertension were about 2.21 times higher compared 
to people with normal BMI and the odds for central obese people were 1.48 times higher as 
compared to people without central obesity after adjusting for the covariates.  
In WHO classification, all covariates except for former smokers were significantly 
associated with hypertension. The odds for general obese people to get hypertension were 
about 2.61 times higher compared to people with normal BMI and the odds for central obese 
people were 1.50 times higher compared to people without central obesity after adjusting for 
the covariates.  
  
 
Table and Figure legends 
Table 1. Prevalence of hypertension by characteristics1 
 Total Normotensive  %  Hypertensive  %  P 
N 313,714 210,889  67.2  102,825  32.8   
Age group           
Young 148,103 123,363  83,3  24,740  16,7  
<0.001 Middle 101,841 61,237  60,1  40,604  34,3  
Old 63,770 26,289  41,2  37,481  58,8  
Place of living           
Urban 146,796 97,821  66.6  48,975  33.4  <0.001 Rural  166,918 113,068  67.7  53,850  32.3  
 
Marital status           
Single 80,260 54,109  67.4  26,151  32.6  0.175 Married 233,454 156,780  67.2  76,674  32.8  
 
Educational attainment           
Less than high school 218,996 137,361  62.7  81,635  37.3  
<0.001 High school 71,595 55,788  77.9  15,807  22.1  
More than high school 23,123 17,740  76.7  5,383  23.3  
 
Physical activity           
Active 147,583 99,124  67.2  48,459  32.8  0.512 Less active 166,131 111,765  67.3  54,366  32.7  
 
Cardiovascular disease           
Yes 2,445 891  36.4  1,554  63.6  <0.001 No 311,269 209,998  67.5  101,271  32.5  
 
Chronic kidney disease           
Yes 683 326  47.7  357  52.3  <0.001 No 313,031 210,563  67.3  102,468  32.7  
 
Self-reported smoking 
status 
          
Never 302,920 204,251  67.4  98,669  32.6  
<0.001 Former  2,648 1,501  56.7  1,147  43.3  
Current 8,146 5,137  63.1  3,009  36.9  
 
Diabetes mellitus           
Yes 6,617 2,578  39.0  4,039  61.0  <0.001 No 307,097 208,311  67.8  98,786  32.2  
 
Hyperthyroid           
Yes 1,956 1,151  58.8  805  41.2  <0.001 No 311,758 209,738  67.3  102,020  32.7  
 
Indonesia Classification           
BMI           
Normal       176,971 129,285  73.1  47,686  26.9  
< 0.001 Overweight   40,653 25,197  62.0  15,456  38.0  
Obese            63,258 32,373  51.2  30,885  48.8  
 
Central obesity           
No  168,409 126,339  75.0  42,070  25.0  
< 0.001 Yes  145,305 84,550  58.2  60,755  41.8  
 
WHO classification           
BMI           
Normal       176,971 129,285  73.1  47,686  26.9  < 0.001 Overweight   77,373 45,396  58.7  31,977  41.3  
                                                     
1 Calculated using SPSS version 22 
Obese            26,538 12,174  45.9  14,364  54.1  
 
Central obesity           
No  249,492 179,034  71.8  70,458  28.2  
< 0.001 
Yes  64,222 31,855  49.6  32,367  50.4  
 
 
 
 
Table 2. Characteristics comparison between hypertensive and normotensive groups2 
 
 Hypertensive    Normotensive    P-value 
M   SD   M   SD   
Age (year) 50.07   14.33    38.04    13.57   < 0.001 
Weight (kg) 56.24   12.33    53.27    10.18   < 0.001 
Height (cm) 150.42   6.50    152.14    6.17   < 0.001 
BMI (kg/m2) 24.80   4.98    23.00    4.16   < 0.001 
WC (cm) 82.29   12.44    77.27    10.67   < 0.001 
SBP (mmHg) 150.73   23.06    115.55    11.22   < 0.001 
DBP (mmHg) 95.68    11.42     76.95     7.32    < 0.001 
 
 
 
 
 
 
 
 
 
                                                     
2 Calculated using SPSS ver 2.3 
 Ta
bl
e 
3.
 L
og
is
tic
 re
gr
es
si
on
 a
na
ly
si
s 
1 
 
2 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
3  A
dj
us
te
d 
od
ds
 ra
tio
 
 
Hy
pe
rt
en
sio
n 
In
do
ne
sia
n 
Cl
as
sif
ic
at
io
n 
W
HO
 C
la
ss
ifi
ca
tio
n 
O
R 
(9
5%
 C
I) 
aO
R3
 (9
5%
 C
I) 
O
R 
(9
5%
 C
I) 
aO
R 
(9
5%
 C
I) 
Ag
e 
gr
ou
p 
(y
ea
rs
) 
 
 
 
 
  Y
ou
ng
 
- 
- 
- 
- 
  M
id
dl
e 
1.
60
 (1
.5
7-
1.
62
) 
2.
75
 (2
.7
0-
2.
80
) 
1.
60
 (1
.5
7-
1.
62
) 
2.
78
 (2
.7
2-
2.
83
) 
  O
ld
 
4.
03
 (3
.9
6-
4.
10
) 
6.
79
 (6
.6
4-
6.
95
) 
4.
03
 (3
.9
6-
4.
10
) 
6.
74
 (6
.5
9-
6.
89
) 
Re
si
de
nt
ia
l a
re
a 
 
 
 
 
  U
rb
an
 
- 
- 
- 
- 
  R
ur
al
 
0.
95
 (0
.9
4-
0.
97
) 
0.
98
 (0
.9
6-
0.
99
) 
0.
95
 (0
.9
4-
0.
97
) 
0.
97
 (0
.9
5–
0.
99
) 
Ed
uc
at
io
na
l a
tt
ai
nm
en
t 
 
 
 
 
  L
es
s t
ha
n 
hi
gh
 sc
ho
ol
 
2.
06
 (2
.0
3-
2.
10
) 
1.
44
 (1
.4
1-
1.
47
) 
2.
06
 (2
.0
3-
2.
10
) 
1.
44
 (1
.4
1-
1.
47
) 
  H
ig
h 
sc
ho
ol
 
- 
- 
- 
- 
  M
or
e 
th
an
 h
ig
h 
sc
ho
ol
 
0.
60
 (0
.5
8-
0.
62
) 
0.
91
 (0
.8
8-
0.
95
) 
0.
60
 (0
.5
8-
0.
62
 
0.
92
 (0
.8
8-
0.
95
) 
Di
ab
et
es
 m
el
lit
us
 
 
 
 
 
  N
o 
- 
- 
- 
- 
  Y
es
 
3.
30
 (3
.1
4-
3.
47
) 
1.
66
 (1
.5
7-
1.
75
) 
3.
30
 (3
.1
4-
3.
47
) 
1.
68
 (1
.5
9-
1.
78
) 
Se
lf-
re
po
rt
ed
 sm
ok
in
g 
st
at
us
 
 
 
 
 
  N
ev
er
 
- 
- 
- 
- 
  F
or
m
er
 
1.
57
 (1
.4
6-
1.
70
) 
1.
14
 (1
.0
5-
1.
24
) 
1.
57
 (1
.4
6-
1.
70
) 
1.
14
 (1
.0
5-
1.
24
) 
  C
ur
re
nt
 
1.
21
 (1
.1
5-
1.
26
) 
0.
92
 (0
.8
7-
0.
96
) 
1.
21
 (1
.1
5-
1.
26
) 
0.
91
 (0
.8
7-
0.
96
) 
Ch
ro
ni
c 
ki
dn
ey
 d
is
ea
se
 
 
 
 
 
  N
o 
- 
- 
- 
- 
  Y
es
 
2.
25
 (1
.9
4-
2.
62
) 
1.
41
 (1
.1
9-
1.
66
) 
2.
25
 (1
.9
4-
2.
62
) 
1.
39
 (1
.1
7-
1.
64
) 
Ca
rd
io
va
sc
ul
ar
 d
is
ea
se
 
 
 
 
 
  N
o 
- 
- 
- 
- 
  Y
es
 
3.
62
 (3
.3
3-
3.
93
) 
2.
06
 (1
.8
8-
2.
25
) 
3.
62
 (3
.3
3-
3.
93
) 
2.
07
 (1
.8
9-
2.
27
) 
Hy
pe
rt
hy
ro
id
 
 
 
 
 
  N
o 
- 
- 
- 
- 
  Y
es
 
1.
44
 (1
.3
1-
1.
57
) 
1.
20
 (1
.0
9-
1.
33
) 
1.
44
 (1
.3
1-
1.
57
) 
1.
21
 (1
.0
9-
1.
33
) 
BM
I 
 
 
 
 
  N
or
m
al
 
- 
- 
- 
- 
  O
ve
rw
ei
gh
t 
1.
30
 (1
.2
7-
1.
33
) 
1.
44
 (1
.4
1-
1.
48
) 
1.
65
 (1
.6
2-
1.
67
) 
1.
72
 (1
.6
8-
1.
75
) 
  O
be
se
 
2.
37
 (2
.3
3-
2.
41
) 
2.
21
 (2
.1
6-
2.
26
) 
2.
65
 (2
.5
8-
2.
72
) 
2.
61
 (2
.5
2-
2.
70
) 
Ce
nt
ra
l o
be
sit
y 
 
 
 
 
  N
o 
- 
- 
- 
- 
  Y
es
 
2.
16
 (2
.1
3-
2.
19
) 
1.
48
 (1
.4
5-
1.
51
) 
2.
58
 (2
.5
4-
2.
63
) 
1.
50
 (1
.4
6-
1.
53
) 
 4. Discussion 
Hypertension in Indonesia is a growing problem with dramatic increases of raised 
blood pressure in adults from 5% in 1998 to 32% in 2008 (14). In this study, the rate of 
hypertension in Indonesian women using established Indonesia classification was 32.8%. 
Compared to men, the prevalence of both obesity and hypertension in Indonesia is higher in 
women (15). The higher rate of women with hypertension in Indonesia is interesting as other 
south east Asian countries have higher prevalence in men (14). In general, the risk factors 
contributing to the high prevalence of hypertension in Indonesia may be due to an aging 
population, genetic factors, less physical activity, and an inappropriate diet that may lead to 
the increasing prevalence of obesity (15,16).  
Hypertension is significantly associated with residential area, educational attainment, 
cardiovascular disease, chronic kidney disease, smoking, diabetes mellitus, hyperthyroid, BMI, 
and WC. People living in urban areas, married people, and former smokers, tend to have 
higher hypertension prevalence. People with diabetes mellitus, hyperthyroid, cardiovascular 
or chronic kidney disease have higher hypertension prevalence compared to those without 
the above diseases.  
 Hypertension prevalence is increasing respective to weight gain. In this study, 48.8% 
of obese people have hypertension by using Indonesian cut-off value, and 54.1% of obese 
people have hypertension by using WHO cut-off value. The results are similar to previous 
findings in which higher BMI resulted in higher prevalence of hypertension (16–18). Several 
mechanisms support the effect of weight gain on increasing blood pressure. Both total body 
fat described as BMI and abdominal fat described as WC affect blood pressure by several 
mechanisms including insulin resistance, which results in greater fatty acid release 
attributable to hypertension and the other mechanism, adipokines release such as leptin by 
increasing sympathetic outflow (5,19).  
 These physiological mechanisms support the major finding in this study that, after 
adjusting for all covariates, general and central obesity were associated with hypertension in 
Indonesian women according to established Indonesian or WHO classifications for obesity. 
Indonesian women with general obesity have a twofold excess risk to developing 
hypertension compared to non-obese members of the population. The previous finding found 
that the increasing trend of being overweight or obese among  women caused by higher 
 socioeconomic status and residence in urban areas has a strong connection with the risk to 
have high blood pressure (20).  
In detail, based on Indonesia classification, the odds for generally obese people to 
develop hypertension were 2.21 times higher compared to people with normal BMI and the 
odds for abdominally obese people were 1.48 times higher, as compared to people without 
abdominal obesity after adjusting for the covariates. Using WHO classification, the odds for 
generally obese people to get hypertension were about 2.61 times higher compared to 
people with normal BMI and the odds for abdominally obese people were 1.50 times higher 
compared to people without abdominal obesity after adjusting for the covariates.  
 The result in this study showed that having abdominal obesity will also give a risk to 
get hypertension. The association and odds of hypertension is consistent with several 
previous studies (21–23), one previous study stated in detail that for every additional 1 cm in 
waist circumference, the odds for hypertension is 1.04 times higher (24). Therefore, both BMI 
and waist circumference should be examined to assess hypertension in Indonesian women. 
This is consistent with the a previous study that suggests using not only BMI but also WC as 
significant predictors of hypertension in the population (25).  
 Both general and central obesity assessment are important to improve the evaluation 
of potential health risks and to provide accurate prognosis by estimating fat distributions. 
Additionally, previous research found that each fat depots such as lower body, upper body 
and visceral have unique characteristics related to the metabolism of fatty acid (26). For 
people at risk who tend to store their excess weight abdominally, determination of waist 
circumference will help to improve the treatment (27). Therefore, in assessing patients with 
health risks associated with obesity, measuring waist circumference as a complement of 
simple BMI measurement is necessary. 
 The odds of having hypertension and the rate of general as well as central obesity 
using the Indonesia classification differed from WHO classification. In general, Asian people 
are likely to have a higher percentage of total body fat and central adiposity compared to 
Caucasian people (10,27). Considering this difference, the International diabetes federation 
suggested a threshold for waist circumference is more than or equivalent to 80 cm for Asian 
women (28). Another research conducted on a population in Pakistan found out that a 
quarter of the study population was classified as overweight or obese using the Asian cut-offs 
 (9). The use of a lower BMI classification may provide reliable estimation and optimal 
identification of obesity-related disease risks in Asian populations (29).  
The large sample size equipped with various confounders and nationally representative data 
increased the validity of this study. Nevertheless, one limitation of this study is it is cross-
sectional study that gives only a one-time measurement for classifying the BMI and WC score 
from the participants. Therefore, it is difficult to state a direct causal inference. Further 
longitudinal studies are needed to asses the effect size of general and central obesity on 
hypertension. 
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